VENTOLIN HFA Drug Patent Profile
✉ Email this page to a colleague
When do Ventolin Hfa patents expire, and when can generic versions of Ventolin Hfa launch?
Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in VENTOLIN HFA is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ventolin Hfa
A generic version of VENTOLIN HFA was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VENTOLIN HFA?
- What are the global sales for VENTOLIN HFA?
- What is Average Wholesale Price for VENTOLIN HFA?
Summary for VENTOLIN HFA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Clinical Trials: | 51 |
Patent Applications: | 5,404 |
Drug Prices: | Drug price information for VENTOLIN HFA |
Drug Sales Revenues: | Drug sales revenues for VENTOLIN HFA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VENTOLIN HFA |
What excipients (inactive ingredients) are in VENTOLIN HFA? | VENTOLIN HFA excipients list |
DailyMed Link: | VENTOLIN HFA at DailyMed |
Recent Clinical Trials for VENTOLIN HFA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Alberta | Phase 1 |
Canisius-Wilhelmina Hospital | Phase 3 |
Hat Yai Medical Education Center | Phase 3 |
Pharmacology for VENTOLIN HFA
Drug Class | beta2-Adrenergic Agonist |
Mechanism of Action | Adrenergic beta2-Agonists |
US Patents and Regulatory Information for VENTOLIN HFA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | BX | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VENTOLIN HFA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VENTOLIN HFA
See the table below for patents covering VENTOLIN HFA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 3085292 | ⤷ Sign Up | |
Czech Republic | 9902323 | ⤷ Sign Up | |
Cyprus | 2493 | Aerosol compositions. | ⤷ Sign Up |
Portugal | 1145987 | ⤷ Sign Up | |
Portugal | 820279 | ⤷ Sign Up | |
Japan | 2007210680 | DEVICE HOUSING FOR AEROSOL CONTAINER | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |